- $988.71m
- $891.50m
- $291.65m
- 99
- 20
- 91
- 81
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 48.03 | ||
PEG Ratio (f) | 18.17 | ||
EPS Growth (f) | 2.72% | ||
Dividend Yield (f) | 0.37% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.75 | ||
Price to Tang. Book | 14.28 | ||
Price to Free Cashflow | 33.5 | ||
Price to Sales | 3.39 | ||
EV to EBITDA | 14.24 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 5.39% | ||
Return on Equity | 5.72% | ||
Operating Margin | 7.3% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 244.83 | 256.71 | 266.83 | 279.06 | 291.65 | 304.62 | 321.85 | 2.79% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +0.62 | -58.03 | +112.93 | +26 | +32.07 | +0.76 | +7.27 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
HealthStream, Inc. provides platform-delivered workforce solutions. Its solutions include Software-as-a-Service (SaaS), subscription-based applications used by healthcare organizations to meet a range of their workforce development needs around learning, clinical development, credentialing, and scheduling. Its content libraries allow customers to subscribe to an array of courseware, which includes content from healthcare and nursing associations, medical and healthcare publishers, and other content providers. Its scheduling solutions provide customers with real-time visibility into clinical staff scheduling. Its credentialing, privileging, and enrollment solution, CredentialStream, provides customers a user experience with a continual stream of enhancements, evidence-based content, and curated data, which provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure, and other credentials.
Directors
- Robert Frist CHM (54)
- J. Edward Pearson PRE (58)
- Scott Roberts CFO (44)
- Jeffrey Cunningham SVP (54)
- Michael Collier SVP (45)
- Trisha Coady SVP (45)
- M. Scott McQuigg SVP (53)
- Kevin O'Hara SVP (51)
- Scott Fenstermacher SVP (52)
- Michael Sousa SVP (52)
- Thompson Dent LED (71)
- Terry Rappuhn DRC (64)
- Frank Gordon IND (58)
- Jeffrey McLaren IND (54)
- Linda Rebrovick IND (65)
- Michael Shmerling IND (65)
- William Stead IND (72)
- Deborah Tate IND (64)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 27th, 1990
- Public Since
- April 11th, 2000
- No. of Shareholders
- 12,806
- No. of Employees
- 1,083
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Global Select Market
- Shares in Issue
- 30,525,266

- Address
- 500 11Th Avenue North, Suite 850, NASHVILLE, 37203
- Web
- https://www.healthstream.com/
- Phone
- +1 6153013100
- Contact
- Mollie Condra
- Auditors
- Ernst & Young LLP
Upcoming Events for HSTM
HealthStream Inc Annual Shareholders Meeting
Q2 2025 HealthStream Inc Earnings Release
Q3 2025 HealthStream Inc Earnings Release
FAQ
As of Today at 21:03 UTC, shares in HealthStream are trading at $32.39. This share price information is delayed by 15 minutes.
Shares in HealthStream last closed at $32.39 and the price had moved by +32.37% over the past 365 days. In terms of relative price strength the HealthStream share price has outperformed the S&P500 Index by +24.46% over the past year.
The overall consensus recommendation for HealthStream is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe HealthStream dividend yield is 0.35% based on the trailing twelve month period.
Last year, HealthStream paid a total dividend of $0.11, and it currently has a trailing dividend yield of 0.35%. We do not have any data on when HealthStream is to next pay dividends.
We do not have data on when HealthStream is to next pay dividends. The historic dividend yield on HealthStream shares is currently 0.35%.
To buy shares in HealthStream you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $32.39, shares in HealthStream had a market capitalisation of $988.71m.
Here are the trading details for HealthStream:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: HSTM
Based on an overall assessment of its quality, value and momentum HealthStream is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in HealthStream is $35.00. That is 8.06% above the last closing price of $32.39.
Analysts covering HealthStream currently have a consensus Earnings Per Share (EPS) forecast of $0.66 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like HealthStream. Over the past six months, its share price has outperformed the S&P500 Index by +24.45%.
As of the last closing price of $32.39, shares in HealthStream were trading +5.49% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The HealthStream PE ratio based on its reported earnings over the past 12 months is 48.03. The shares last closed at $32.39.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
HealthStream's management team is headed by:
- Robert Frist - CHM
- J. Edward Pearson - PRE
- Scott Roberts - CFO
- Jeffrey Cunningham - SVP
- Michael Collier - SVP
- Trisha Coady - SVP
- M. Scott McQuigg - SVP
- Kevin O'Hara - SVP
- Scott Fenstermacher - SVP
- Michael Sousa - SVP
- Thompson Dent - LED
- Terry Rappuhn - DRC
- Frank Gordon - IND
- Jeffrey McLaren - IND
- Linda Rebrovick - IND
- Michael Shmerling - IND
- William Stead - IND
- Deborah Tate - IND